WSJ Tech News Briefing

Plus: BioMarin Pharmaceutical to acquire biotech Amicus Therapeutics for about $4.8 billion. And high-speed trading firm Jump Trading is accused of contributing to the collapse of Terraform Labs. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Plus: BioMarin Pharmaceutical to acquire biotech Amicus Therapeutics for about $4.8 billion. And high-speed trading firm Jump Trading is accused of contributing to the collapse of Terraform Labs. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Plus: TikTok signs deal to create new U.S. joint venture. And Meta Platforms is developing a new image and video-focused AI model. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices 

As we close out 2025, the IPO market is already heating up. And it’s going to get hotter next year, with some major tech IPOs on the horizon. WSJ reporter Corrie Driebusch shares what’s ahead. Plus, WSJ Heard on the Street columnist Dan Gallagher explains why Micron’s blowout res ...  Afficher plus

Plus: An Iran-linked hacker group targeted a former Israeli prime minister. And defense group Rheinmetall partners with satellite operator ICEYE to supply German armed forces with space reconnaissance. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoi ...  Afficher plus

Plus: Accenture sales rise on AI bookings. And DoorDash teams up with OpenAI to offer grocery shopping in ChatGPT. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices